Statutory Instruments
2024 No. 838
National Health Service, England
The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2024
Made
at 10.30 a.m. on 30th July 2024
Laid before Parliament
at 1.15 p.m. on 30th July 2024
Coming into force
1st September 2024
The Secretary of State makes the following Regulations in exercise of the powers conferred by sections 164(8A)(a), (8B)(b) and (8D) and 272(7) and (8) of the National Health Service Act 2006( 1 ).
Citation, commencement, extent and application
1. —(1) These Regulations may be cited as the National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) Regulations 2024.
(2) These Regulations come into force on 1st September 2024.
(3) These Regulations extend to England and Wales and apply in relation to England only( 2 ).
Amendment of regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013
2. —(1) Regulation 91A of the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013( 3 ) (zero or nominal product reimbursement for coronavirus vaccines and antivirals) is amended as follows.
(2) In its heading, omit “coronavirus”.
(3) In paragraph (2)—
(a) in sub-paragraph (a), omit “(“a coronavirus vaccine”)”;
(b) omit “or” at the end of sub-paragraph (a); and
(c) after sub-paragraph (a) insert—
“ (aa) a drug or medicine which is used for vaccinating or immunising people against respiratory syncytial virus, if the conditions set out in paragraph (3) are satisfied;
(ab) a drug or medicine which is used for vaccinating or immunising people against measles, mumps and rubella, if the conditions set out in paragraph (3) are satisfied; or ” .
(4) In paragraph (3)—
(a) in sub-paragraphs (a) to (c), for “coronavirus” substitute “the” at each place where it occurs (three times); and
(b) in sub-paragraph (d), omit “coronavirus”.
(5) After paragraph (3), insert—
“ (3A) The references in paragraph (3) to vaccines or the vaccine in question are references to the drugs or medicines in respect of which the conditions set out in paragraph (3) are to be satisfied by virtue of paragraph (2)(a) to (ab). ” .
Signed by authority of the Secretary of State for Health and Social Care
Stephen Kinnock
Minister of State
Department of Health and Social Care
At 10.30 a.m. on 30th July 2024
2006 c. 41 . In section 164, subsections (8A) to (8E) were inserted by the Health Service Medical Supplies (Costs) Act 2017 (c. 23) , section 1, and subsections (8A) and (8D) were thereafter amended by the Health and Care Act 2022 (c. 31) , section 161(1)(a) to (c). See section 275(1) of the National Health Service Act 2006 for the meanings given to “prescribed” and “regulations” which are relevant to the powers being exercised.
See section 271(1) of the National Health Service Act 2006, by virtue of which the functions of the Secretary of State being exercised in the making of these Regulations are exercisable only in relation to England.
S.I. 2013/349 ; regulation 91A was inserted by S.I. 2022/930 .